{"id":"abciximab-intravenously","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"5-10%","effect":"Bleeding"},{"rate":"1-2%","effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL1201584","moleculeType":"Antibody"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This prevents platelet activation and aggregation, thereby reducing thrombus formation. Abciximab is a monoclonal antibody that binds to the glycoprotein IIb/IIIa receptor on platelets, blocking the binding of fibrinogen and other ligands, which are essential for platelet aggregation.","oneSentence":"Abciximab inhibits platelet aggregation by binding to the glycoprotein IIb/IIIa receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:47:19.334Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Percutaneous coronary intervention"}]},"trialDetails":[{"nctId":"NCT00712101","phase":"PHASE3","title":"Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction","status":"COMPLETED","sponsor":"University of Leipzig","startDate":"2008-07","conditions":"ST-elevation Myocardial Infarction","enrollment":1912}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"abciximab intravenously","genericName":"abciximab intravenously","companyName":"University of Leipzig","companyId":"university-of-leipzig","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Abciximab inhibits platelet aggregation by binding to the glycoprotein IIb/IIIa receptor. Used for Acute coronary syndrome, Percutaneous coronary intervention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}